[ad_1]
While many countries are struggling with the second wave of the corona virus outbreak, corona virus vaccines produced by Pfizer, which cooperates with the American pharmaceutical giant and German biotech company BioNTech, and American biotech company Moderna, have started to be distributed.
According to Wall Street Stock Exchange analysts, Pfizer / BioNTech and Moderna will earn a total of $ 32 billion from the sale of Covid-19 vaccines in 2021.
BioNtech’s founding partner, Uğur Şahin, and his wife, Dr. Ozlem Türeci
PFIZER WILL GENERATE 19 BILLION DOLLARS IN REVENUE IN 2021
According to the report released by the US investment bank Morgan Stanley in New York City, the Pfizer company is expected to generate $ 19 billion in revenue from the corona virus vaccine in 2021.
Morgan Stanley reported that Pfizer will earn $ 975 million in vaccines in 2020, while it will earn another $ 9.3 billion in coronavirus vaccines in 2022-2023.
Pfizer will share its profits with the German company BioNTech with which it collaborates. Last Friday, Mexico approved Pfizer to use the corona virus vaccine in emergency situations. It was the fifth country after Mexico, the United Kingdom, Bahrain, Canada and Saudi Arabia.
FULLY EFFECTIVE AGAINST TRANSMISSION
US-based Moderna shared the results of the third phase of the corona virus vaccine with the public in the days we left behind. In the statement made, it was indicated that there were no side effects in the third phase of the vaccine, and it was emphasized that the vaccine prevented the transmission of Covid-19 by 100 percent. As a result of investigating 196 Covid-19 cases, the vaccine was claimed to be 94.1 percent effective.
MODERN WILL HAVE INCOME OF 13.2 BILLION DOLLARS
According to information released by the US investment bank Goldman Sachs, the US biotech company Moderna is expected to earn $ 13.2 billion from the corona virus vaccine it developed. Morgan Stanley stated that Moderna investors are expected to earn $ 10-15 billion from vaccine sales in 2021 and 2022. (İHA)
It may interest you
It may interest you
It may interest you
[ad_2]
